Viewing StudyNCT04006288



Ignite Creation Date: 2024-05-06 @ 1:22 PM
Last Modification Date: 2024-10-26 @ 1:13 PM
Study NCT ID: NCT04006288
Status: COMPLETED
Last Update Posted: 2023-04-26
First Post: 2019-06-25

Brief Title: Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
Sponsor: University of Florida
Organization: University of Florida

Conditions & Keywords Data

Conditions:
Name
Coronary Artery Disease
Keywords:
Name View
pharmacodynamic View
dual antiplatelet therapy View
rivaroxaban View